EGFR and central nervous system cancer: At the molecular level, Bcan and its cleaved products are secreted by the tumor cells, and activate EGFR/mitogen-activated protein kinase (MAPK) signaling and fibronectin production in glioma cells to enhance cell adhesion, migration, and invasive characteristics [30].